Has Ashleigh Byrne, MD received payments from drug or device companies?

Yes. Drug and device makers reported $10,600 in general payments to Ashleigh Byrne, MD across 457 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ashleigh Byrne, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ashleigh Byrne, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ashleigh Byrne, MD

Interventional Pain Medicine · West Jordan, UTNPI 1023269537

Payments from drug & device makers

$10,600in general payments, 2019–2025

Across 457 payments — averaging $23.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$5K
Medtronic$2K
AbbVie$690
Globus Medical$423
Nevro Corp.$373
Collegium Pharmaceutical, Inc.$327
plus $2K from 36 others

What the payments were for

Consulting fees$3,20030%
Travel & lodging$8088%
Food & beverage$6,59262%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	63	$4,784
Medtronic(2 entities)	180	$1,809
AbbVie(2 entities)	39	$690
Globus Medical	11	$423
Nevro Corp.	17	$373
Collegium Pharmaceutical, Inc.	24	$327
Pfizer	20	$251
Averitas Pharma Inc.	7	$194
Lundbeck LLC	11	$193
Biotronik NRO, Inc.	3	$159
Abbott	8	$131
Indivior Inc.	6	$124
Nalu Medical, Inc.	6	$121
Amgen(2 entities)	6	$96
Biodelivery Sciences International, Inc.	5	$85
Novartis	4	$83
Braeburn Inc.	4	$78
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	5	$74
Ferring Pharmaceuticals Inc.	4	$59
Vertex	3	$57
Teva Pharmaceuticals USA, Inc.	4	$52
Biohaven Pharmaceuticals, Inc.	2	$47
Shionogi Inc	2	$37
Relievant Medsystems, Inc.	2	$31
Zyla Life Sciences, Inc.	2	$30
Kaleo, Inc.	2	$28
Supernus Pharmaceuticals, Inc.	2	$25
Sonex Health, Inc.	1	$23
Avanos Medical	1	$21
Sanofi	1	$20
SPR Therapeutics, Inc	1	$20
Redhill Biopharma Inc.	1	$18
Idorsia Pharmaceuticals US Inc	1	$18
Si-bone, Inc.	1	$16
Almatica Pharma LLC	1	$16
GRT US Holding, Inc.	1	$15
Sanofi-aventis U.S. LLC	1	$14
Daiichi Sankyo Inc.	1	$14
Lilly USA, LLC	1	$13
Assertio Therapeutics, Inc.	1	$12
AstraZeneca	1	$12
Stimwave Technologies Incorporated	1	$8

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,600 in reported general payments places this provider in the 60th percentile of 26 interventional pain medicine providers in Utah.

See all interventional pain medicine providers in Utah →

Medicare billing

Part B allowed, 2024

$280,475

Medicare patients

332

Services billed

6,611

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Buprenorphine	13	$2,605
Pregabalin	59	$1,853
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	64	$1,330
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	52	$1,318
Gabapentin	78	$1,120
Buprenorphine Hcl	31	$1,013
Tramadol Hcl	57	$625
Cyclobenzaprine Hcl	46	$608
Tizanidine Hcl	36	$510
Duloxetine Hcl	26	$322
Celecoxib	15	$298
Methylprednisolone	18	$175
Baclofen	11	$167
Morphine Sulfate ErMorphine Sulfate	14	$164
Meloxicam	37	$133

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in West Jordan

Craig DavisWest Jordan$13K
Geeta NagpalWest Jordan$11K
Bryan HoelzerVineyard$718K
Gregory CondieMurray$236K
Alex NelsonMurray$46K
Nathan ClementsSaint George$29K
Rick ObraySt George$23K
Brian RichardsonLogan$19K
Steven LarsenSaint George$14K
J Riley StringhamProvo$13K

See the full list for Utah →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →